Skip to content
  1. EMEA Innovative Medicine /
  2. Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose

Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose

Johnson & Johnson Announces Submission of Application to the European Medicines Agency (EMA) for use of its COVID-19 Vaccine as a Booster Dose